Overview
Capivasertib has been investigated for the treatment of Metastatic Breast Cancer.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/05/21 | Phase 3 | Not yet recruiting | |||
2025/01/08 | Phase 3 | Recruiting | |||
2024/10/10 | Phase 3 | Recruiting | |||
2024/09/26 | Phase 2 | Not yet recruiting | |||
2024/09/23 | Phase 2 | Recruiting | |||
2023/02/09 | Phase 2 | Recruiting | |||
2022/10/25 | Phase 2 | Recruiting | |||
2022/10/03 | Phase 1 | Recruiting | |||
2022/06/15 | Phase 1 | Completed | |||
2022/04/27 | Phase 3 | Active, not recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 0310-9500 | ORAL | 160 mg in 1 1 | 11/16/2023 | |
| AstraZeneca Pharmaceuticals LP | 0310-9501 | ORAL | 200 mg in 1 1 | 11/16/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
Authorised | 6/17/2024 |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| TRUQAP FILM-COATED TABLETS 200MG | SIN17111P | TABLET, FILM COATED | 200mg | 10/14/2024 | |
| TRUQAP FILM-COATED TABLETS 160MG | SIN17112P | TABLET, FILM COATED | 160mg | 10/14/2024 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| TRUQAP TABLETS 160MG | N/A | N/A | N/A | 12/16/2024 | |
| TRUQAP TABLETS 200MG | N/A | N/A | N/A | 12/16/2024 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| TRUQAP capivasertib 160 mg film coated tablet blister pack | 407961 | Medicine | A | 5/9/2024 | |
| TRUQAP capivasertib 200 mg film coated tablet blister pack | 407960 | Medicine | A | 5/9/2024 |
Help Us Improve
Your feedback helps us provide better drug information and insights.